Belumosudil mesylate | m-entrepreneurship.com

Product Name :
Belumosudil mesylate

Search keywords :
Belumosudil (mesylate)

drugId :
null

Target Vo:
Rho-associated protein kinase 2

Target Vo Short Name :
ROCK2

Moa_Name:
Rho-associated protein kinase 2 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2021

Origin Company_Name :
Nabriva Therapeutics Plc

Active Company_Name :
Bionova Pharmaceuticals (Shanghai) Ltd

Active Indication_Name:
Graft vs Host Disease

In Active Indication_Name:
Scleroderma, Diffuse

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Interferon alfa Biological Activity
Teplizumab manufacturer
ATM Antibody: ATM Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 351 kDa, targeting to ATM. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts